An investigational outpatient endoscopic procedure may help eliminate the need for insulin in people with Type 2 diabetes, early research suggests. Called re-cellularization via electroporation
Embecta, the largest maker of disposable pen needles and insulin syringes for people withy diabetes, has announced plans to develop its own insulin pump, signaling